Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119505267 | 11950526 | 7 | F | 20160321 | 20160906 | 20160126 | 20160920 | PER | US-PFIZER INC-2016012062 | PFIZER | 65.00 | YR | F | Y | 84.36000 | KG | 20160920 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119505267 | 11950526 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 37.5 MG, DAILY, CYCLIC (28 DAYS ON AND 14 DAYS OFF) | Y | X731C | 21938 | 37.5 | MG | CAPSULE, HARD | |||||
| 119505267 | 11950526 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 37.5 MG, CYCLIC (DAYS 1-14 Q 21 DAYS) | Y | 258CA | 21938 | 37.5 | MG | CAPSULE, HARD | |||||
| 119505267 | 11950526 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 37.5 MG, CYCLIC (DAYS 1-14 Q 21 DAYS) | Y | 440CB | 21938 | 37.5 | MG | CAPSULE, HARD | |||||
| 119505267 | 11950526 | 4 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 37.5 MG, CYCLIC (2 WEEKS ON, 1 OFF) | Y | 21938 | 37.5 | MG | CAPSULE, HARD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119505267 | 11950526 | 1 | Gastrointestinal stromal tumour |
| 119505267 | 11950526 | 2 | Breast cancer metastatic |
| 119505267 | 11950526 | 3 | Colon cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119505267 | 11950526 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119505267 | 11950526 | Diarrhoea | |
| 119505267 | 11950526 | Gait disturbance | |
| 119505267 | 11950526 | Hyperkeratosis | |
| 119505267 | 11950526 | Oral pain | |
| 119505267 | 11950526 | Pain in extremity | |
| 119505267 | 11950526 | Product use issue | |
| 119505267 | 11950526 | Skin disorder | |
| 119505267 | 11950526 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119505267 | 11950526 | 1 | 20150316 | 0 | ||
| 119505267 | 11950526 | 2 | 20150321 | 20160610 | 0 | |
| 119505267 | 11950526 | 3 | 20160321 | 0 | ||
| 119505267 | 11950526 | 4 | 201503 | 0 |